Pharmalicensing brings you advice, commentary and analysis from industry experts.
Drug & Market Development Newsletter is published twelve times each year. The newsletter provides in-depth reviews of current R&D developments in the pharmaceutical and biotechnology industries.
Drug & Market Development Publications, a division of Informa Group plc, publishes D&MD Newsletter and D&MD Reports. Our publications are designed to bring detailed, comprehensive business and technology information to pharmaceutical and biotechnology executives working in R&D, business development and marketing. D&MD Newsletter is monthly newsletter designed to help track the R&D developments and asses market trends of the pharmaceutical and biotechnology field, featuring regular features on: * Technology & Strategy Issues * Industry Meetings * Therapeutic & Market Updates * Cardiovascular & Blood-related Diseases * Central Nervous Systems * Inflammatory & Infectious Diseases * Cancer * International Issues * Company Profiles D&MD Reports are in-depth market research reports that feature: * Comprehensive summaries and analysis of markets * In-depth profiles of leading companies and alliances * Reviews of key trends and market drivers * Implications for long term profit potential * Availability in CD-ROM and print formats Recent titles include: Overcoming Formulations Challenges, Functional Genomics, Pain Therapeutics, GPCRs, Nanobiotechnology, SNPs, Commercial Opportunities in Enzyme Technologies, Generic Drugs, Vaccines, Antibody Therapeutics, Transgenic Plants. Drug & Market Development Publications One Research Drive, P.O. Box 5194, Westborough, MA 01581-5194, USA 508-616-5566 (phone) 508-616-5544 (fax)